Aptevo Therapeutics Inc.
APVO· Nasdaq
APVOAptevo Therapeutics Inc.
Filed Mar 18, 2019 · 10-K · 77 days after period end · 0001564590-19-008184
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Revenue | $6.35M | $2.82M | $8.77M | $8.29M |
| Net Income | -$14.13M | -$9.76M | -$14.95M | -$17.90M |
| EPS Diluted | — | — | -$0.74 | -$0.88 |
Aptevo Therapeutics Inc. · CIK 1671584 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2018 · filed Mar 18, 2019 · 77 d after period end
